Phase IV is essential because it provides real-world data that can confirm the benefits and risks of a treatment observed in earlier clinical trials. It helps in understanding how the treatment works in a broader population, including groups that may not have been adequately represented in earlier phases. This phase can also lead to the discovery of new therapeutic uses for the drug or the identification of previously unknown adverse effects.
